FIELD: medicine.
SUBSTANCE: group of inventions concerns medicine and covers normalisation of sleep/wakefulness cycle in a mammal, and also to increasing its cognitive function. It involves introduction of therapeutically effective amount of the compound chosen from the group including cytosine, cytidine, cytidine monophosphate, cytidine triphosphate, deoxycytidine monophosphate, deoxycytidine diphosphate or deoxycytidine triphosphate, cytidine diphosphate - choline, cytidine diphosphate sodium choline, uridine, uridine triphosphate, uridine diphosphate, uridine monophosphate and triacetyluridine. Said mammal does not suffer from insomnia.
EFFECT: offered methods reduce asthenia or fatigue during a day, improve sleep quality, besides, they can be used in treatment of somnipathies, including sleep apnea, periodic limb movements, a restless leg syndrome, narcolepsy and somnolency problem, or in increasing cognitive functions in the sleep deprived patients.
18 cl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS FOR TOBACCO ADDICTION TREATMENT AND GETTING RID OF SMOKING HABIT | 2003 |
|
RU2329811C2 |
| INJECTION FORM OF PHARMACEUTICAL COMPOSITION (VERSIONS) FOR PREVENTING AND TREATING NEUROPATHIES AND METHOD FOR PREPARING IT | 2010 |
|
RU2448706C2 |
| METHOD FOR IMPROVING BLADDER FUNCTION | 2016 |
|
RU2715247C2 |
| NUTRITIVE PRODUCT FOR REDUCING PHENYLALANINE LEVELS IN THE PATIENTS WITH PKU | 2016 |
|
RU2740905C2 |
| PLEASANT TASTING NUTRITIONAL COMPOSITION CONTAINING NUCLEOTIDE AND/OR NUCLEOSIDE AND AGENT MASKING TASTE | 2008 |
|
RU2484670C2 |
| METHOD FOR IMPROVING FUNCTIONAL SYNAPTIC CONNECTIVITY | 2013 |
|
RU2667968C2 |
| POLYNUCLEOTIDES CODING INTERLEUKIN-12 (IL12), AND APPLICATIONS THEREOF | 2017 |
|
RU2769316C2 |
| LIQUID PRODUCT CONTAINING NUCLEOTIDES/NUCLEOSIDES | 2008 |
|
RU2446807C2 |
| COMBINATION OF COMPONENTS FOR PREVENTION AND TREATMENT OF INDISPOSITION | 2011 |
|
RU2646830C2 |
| MODIFIED NUCLEOSIDE, NUCLEOTIDE AND NUCLEIC ACID COMPOSITIONS | 2012 |
|
RU2649364C2 |
